These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33177116)

  • 21. Association of Infection With Human Papillomavirus and Development of End-Stage Kidney Disease in Taiwan.
    Chang R; Chen ML; Lin CL; Hung YM; Wei JC
    JAMA Netw Open; 2020 Oct; 3(10):e2022107. PubMed ID: 33090225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma D-dimer as a potential predictor of progression in IgA nephropathy: a cohort study.
    Yu G; Jiang Y; Xu Z; Cheng J; Li H; Li X; Chen J
    Ren Fail; 2023; 45(2):2251587. PubMed ID: 37724549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
    Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
    Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy.
    Thompson A; Carroll K; A Inker L; Floege J; Perkovic V; Boyer-Suavet S; W Major R; I Schimpf J; Barratt J; Cattran DC; S Gillespie B; Kausz A; W Mercer A; Reich HN; H Rovin B; West M; Nachman PH
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):469-481. PubMed ID: 30635299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
    Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
    Jiang Z; Tan J; Wang S; Dong L; Han X; Tang Y; Qin W
    Int J Med Sci; 2021; 18(13):2964-2970. PubMed ID: 34220324
    [No Abstract]   [Full Text] [Related]  

  • 28. The Added Value of Crescents on Oxford Classification Score in Risk Stratification of End-stage Kidney Disease in Patients with IgA Nephropathy.
    Ossareh S; Nazemzadeh N; Asgari M; Bagherzadegan H; Afghahi H
    Iran J Kidney Dis; 2022 Mar; 16(2):115-124. PubMed ID: 35489080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin A nephropathy and ischemic heart disease: a nationwide population-based cohort study.
    Jarrick S; Lundberg S; Sundström J; Symreng A; Warnqvist A; Ludvigsson JF
    BMC Nephrol; 2021 May; 22(1):165. PubMed ID: 33952193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteinuria during Follow-Up Period and Long-Term Renal Survival of Childhood IgA Nephropathy.
    Kamei K; Harada R; Hamada R; Sakai T; Hamasaki Y; Hataya H; Ito S; Ishikura K; Honda M
    PLoS One; 2016; 11(3):e0150885. PubMed ID: 26978656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Inflammatory Bowel Disease and Celiac Disease in Patients with IgA Nephropathy over Time.
    Nurmi R; Pohjonen J; Metso M; Pörsti I; Niemelä O; Huhtala H; Mustonen J; Kaukinen K; Mäkelä S
    Nephron; 2021; 145(1):78-84. PubMed ID: 33271538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy.
    Okada S; Samejima KI; Matsui M; Morimoto K; Furuyama R; Tanabe K; Eriguchi M; Akai Y; Saito Y; Tsuruya K
    BMJ Open Diabetes Res Care; 2020 Nov; 8(2):. PubMed ID: 33148691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease.
    Barbour SJ; Cattran DC; Kim SJ; Levin A; Wald R; Hladunewich MA; Reich HN
    Kidney Int; 2013 Nov; 84(5):1017-24. PubMed ID: 23739233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathologic features aid in predicting risk for progression of IgA nephropathy.
    Walsh M; Sar A; Lee D; Yilmaz S; Benediktsson H; Manns B; Hemmelgarn B
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):425-30. PubMed ID: 20089495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. End-Stage Kidney Diseases in Immigrant Groups: A Nationwide Cohort Study in Sweden.
    Wändell P; Carlsson AC; Li X; Gasevic D; Ärnlöv J; Sundquist J; Sundquist K
    Am J Nephrol; 2019; 49(3):186-192. PubMed ID: 30712037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Childhood Cancer and the Risk of ESKD.
    Calderon-Margalit R; Pleniceanu O; Tzur D; Stern-Zimmer M; Afek A; Erlich T; Verhovsky G; Keinan-Boker L; Skorecki K; Twig G; Vivante A
    J Am Soc Nephrol; 2021 Feb; 32(2):495-501. PubMed ID: 33184124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of IgA Nephropathy after Kidney Transplantation in Adults.
    Uffing A; Pérez-Saéz MJ; Jouve T; Bugnazet M; Malvezzi P; Muhsin SA; Lafargue MC; Reindl-Schwaighofer R; Morlock A; Oberbauer R; Buxeda A; Burballa C; Pascual J; von Moos S; Seeger H; La Manna G; Comai G; Bini C; Russo LS; Farouk S; Nissaisorakarn P; Patel H; Agrawal N; Mastroianni-Kirsztajn G; Mansur J; Tedesco-Silva H; Ventura CG; Agena F; David-Neto E; Akalin E; Alani O; Mazzali M; Manfro RC; Bauer AC; Wang AX; Cheng XS; Schold JD; Berger SP; Cravedi P; Riella LV
    Clin J Am Soc Nephrol; 2021 Aug; 16(8):1247-1255. PubMed ID: 34362788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed/advanced glomerulonephritis or unknown cause.
    Lim WH; Wong G; McDonald SP; Chakera A; Luxton G; Isbel NM; Pilmore HL; Barbour T; Hughes P; Chadban SJ
    Sci Rep; 2018 Jun; 8(1):9021. PubMed ID: 29899355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General Population.
    Olén O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
    Gastroenterology; 2019 Feb; 156(3):614-622. PubMed ID: 30342031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.